The global Chronic Gastritis Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chronic Gastritis Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Gastritis Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chronic Gastritis Drugs include GSK, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chronic Gastritis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Gastritis Drugs.
Report Scope
The Chronic Gastritis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Gastritis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Gastritis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
China Resources Sanjiu Pharmaceutical
Sunflower Pharmaceutical
Livzon Pharmaceutical
Segment by Type
Chinese Patent Medicine
Western Medicine
Segment by Application
Hospital
Drug Store
Online Supermarket
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Gastritis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Gastritis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Chronic Gastritis Drugs Market Overview
1.1 Product Overview and Scope of Chronic Gastritis Drugs
1.2 Chronic Gastritis Drugs Segment by Type
1.2.1 Global Chronic Gastritis Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Chinese Patent Medicine
1.2.3 Western Medicine
1.3 Chronic Gastritis Drugs Segment by Application
1.3.1 Global Chronic Gastritis Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Online Supermarket
1.3.5 Others
1.4 Global Chronic Gastritis Drugs Market Size Estimates and Forecasts
1.4.1 Global Chronic Gastritis Drugs Revenue 2019-2030
1.4.2 Global Chronic Gastritis Drugs Sales 2019-2030
1.4.3 Global Chronic Gastritis Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chronic Gastritis Drugs Market Competition by Manufacturers
2.1 Global Chronic Gastritis Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chronic Gastritis Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chronic Gastritis Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Chronic Gastritis Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chronic Gastritis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chronic Gastritis Drugs, Product Type & Application
2.7 Chronic Gastritis Drugs Market Competitive Situation and Trends
2.7.1 Chronic Gastritis Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chronic Gastritis Drugs Players Market Share by Revenue
2.7.3 Global Chronic Gastritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chronic Gastritis Drugs Retrospective Market Scenario by Region
3.1 Global Chronic Gastritis Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chronic Gastritis Drugs Global Chronic Gastritis Drugs Sales by Region: 2019-2030
3.2.1 Global Chronic Gastritis Drugs Sales by Region: 2019-2024
3.2.2 Global Chronic Gastritis Drugs Sales by Region: 2025-2030
3.3 Global Chronic Gastritis Drugs Global Chronic Gastritis Drugs Revenue by Region: 2019-2030
3.3.1 Global Chronic Gastritis Drugs Revenue by Region: 2019-2024
3.3.2 Global Chronic Gastritis Drugs Revenue by Region: 2025-2030
3.4 North America Chronic Gastritis Drugs Market Facts & Figures by Country
3.4.1 North America Chronic Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chronic Gastritis Drugs Sales by Country (2019-2030)
3.4.3 North America Chronic Gastritis Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chronic Gastritis Drugs Market Facts & Figures by Country
3.5.1 Europe Chronic Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chronic Gastritis Drugs Sales by Country (2019-2030)
3.5.3 Europe Chronic Gastritis Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Chronic Gastritis Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Chronic Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chronic Gastritis Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Chronic Gastritis Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Chronic Gastritis Drugs Market Facts & Figures by Country
3.7.1 Latin America Chronic Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chronic Gastritis Drugs Sales by Country (2019-2030)
3.7.3 Latin America Chronic Gastritis Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chronic Gastritis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chronic Gastritis Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chronic Gastritis Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chronic Gastritis Drugs Sales by Type (2019-2030)
4.1.1 Global Chronic Gastritis Drugs Sales by Type (2019-2024)
4.1.2 Global Chronic Gastritis Drugs Sales by Type (2025-2030)
4.1.3 Global Chronic Gastritis Drugs Sales Market Share by Type (2019-2030)
4.2 Global Chronic Gastritis Drugs Revenue by Type (2019-2030)
4.2.1 Global Chronic Gastritis Drugs Revenue by Type (2019-2024)
4.2.2 Global Chronic Gastritis Drugs Revenue by Type (2025-2030)
4.2.3 Global Chronic Gastritis Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Chronic Gastritis Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chronic Gastritis Drugs Sales by Application (2019-2030)
5.1.1 Global Chronic Gastritis Drugs Sales by Application (2019-2024)
5.1.2 Global Chronic Gastritis Drugs Sales by Application (2025-2030)
5.1.3 Global Chronic Gastritis Drugs Sales Market Share by Application (2019-2030)
5.2 Global Chronic Gastritis Drugs Revenue by Application (2019-2030)
5.2.1 Global Chronic Gastritis Drugs Revenue by Application (2019-2024)
5.2.2 Global Chronic Gastritis Drugs Revenue by Application (2025-2030)
5.2.3 Global Chronic Gastritis Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Chronic Gastritis Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Chronic Gastritis Drugs Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Chronic Gastritis Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Chronic Gastritis Drugs Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Chronic Gastritis Drugs Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Procter & Gamble
6.5.1 Procter & Gamble Corporation Information
6.5.2 Procter & Gamble Description and Business Overview
6.5.3 Procter & Gamble Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Procter & Gamble Chronic Gastritis Drugs Product Portfolio
6.5.5 Procter & Gamble Recent Developments/Updates
6.6 Perrigo
6.6.1 Perrigo Corporation Information
6.6.2 Perrigo Description and Business Overview
6.6.3 Perrigo Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Perrigo Chronic Gastritis Drugs Product Portfolio
6.6.5 Perrigo Recent Developments/Updates
6.7 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Chronic Gastritis Drugs Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Chronic Gastritis Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Corporation Information
6.9.2 Teva Pharmaceutical Description and Business Overview
6.9.3 Teva Pharmaceutical Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Pharmaceutical Chronic Gastritis Drugs Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments/Updates
6.10 Nestle
6.10.1 Nestle Corporation Information
6.10.2 Nestle Description and Business Overview
6.10.3 Nestle Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nestle Chronic Gastritis Drugs Product Portfolio
6.10.5 Nestle Recent Developments/Updates
6.11 Boehringer Ingelheim
6.11.1 Boehringer Ingelheim Corporation Information
6.11.2 Boehringer Ingelheim Chronic Gastritis Drugs Description and Business Overview
6.11.3 Boehringer Ingelheim Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Boehringer Ingelheim Chronic Gastritis Drugs Product Portfolio
6.11.5 Boehringer Ingelheim Recent Developments/Updates
6.12 Reckitt Benckiser
6.12.1 Reckitt Benckiser Corporation Information
6.12.2 Reckitt Benckiser Chronic Gastritis Drugs Description and Business Overview
6.12.3 Reckitt Benckiser Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Reckitt Benckiser Chronic Gastritis Drugs Product Portfolio
6.12.5 Reckitt Benckiser Recent Developments/Updates
6.13 Purdue Pharma
6.13.1 Purdue Pharma Corporation Information
6.13.2 Purdue Pharma Chronic Gastritis Drugs Description and Business Overview
6.13.3 Purdue Pharma Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Purdue Pharma Chronic Gastritis Drugs Product Portfolio
6.13.5 Purdue Pharma Recent Developments/Updates
6.14 China Resources Sanjiu Pharmaceutical
6.14.1 China Resources Sanjiu Pharmaceutical Corporation Information
6.14.2 China Resources Sanjiu Pharmaceutical Chronic Gastritis Drugs Description and Business Overview
6.14.3 China Resources Sanjiu Pharmaceutical Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 China Resources Sanjiu Pharmaceutical Chronic Gastritis Drugs Product Portfolio
6.14.5 China Resources Sanjiu Pharmaceutical Recent Developments/Updates
6.15 Sunflower Pharmaceutical
6.15.1 Sunflower Pharmaceutical Corporation Information
6.15.2 Sunflower Pharmaceutical Chronic Gastritis Drugs Description and Business Overview
6.15.3 Sunflower Pharmaceutical Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sunflower Pharmaceutical Chronic Gastritis Drugs Product Portfolio
6.15.5 Sunflower Pharmaceutical Recent Developments/Updates
6.16 Livzon Pharmaceutical
6.16.1 Livzon Pharmaceutical Corporation Information
6.16.2 Livzon Pharmaceutical Chronic Gastritis Drugs Description and Business Overview
6.16.3 Livzon Pharmaceutical Chronic Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Livzon Pharmaceutical Chronic Gastritis Drugs Product Portfolio
6.16.5 Livzon Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Gastritis Drugs Industry Chain Analysis
7.2 Chronic Gastritis Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Gastritis Drugs Production Mode & Process
7.4 Chronic Gastritis Drugs Sales and Marketing
7.4.1 Chronic Gastritis Drugs Sales Channels
7.4.2 Chronic Gastritis Drugs Distributors
7.5 Chronic Gastritis Drugs Customers
8 Chronic Gastritis Drugs Market Dynamics
8.1 Chronic Gastritis Drugs Industry Trends
8.2 Chronic Gastritis Drugs Market Drivers
8.3 Chronic Gastritis Drugs Market Challenges
8.4 Chronic Gastritis Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
GSK
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
China Resources Sanjiu Pharmaceutical
Sunflower Pharmaceutical
Livzon Pharmaceutical
*If Applicable.